Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 12:13 pm Sale |
2024-12-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 4,475,054 6.280% |
-2,615,054![]() (-36.88%) |
Filing History |
2025-02-14 12:11 pm Sale |
2024-12-31 | 13G | Xometry, Inc. XMTR |
Eventide Asset Management, LLC | 3,151,897 6.720% |
-1,266,767![]() (-28.67%) |
Filing History |
2025-02-14 12:08 pm Sale |
2024-12-31 | 13G | Nektar Therapeutics NKTR |
Eventide Asset Management, LLC | 6,650,000 3.610% |
-2,750,000![]() (-29.26%) |
Filing History |
2025-02-14 12:06 pm Sale |
2024-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,606,938 5.430% |
-838,425![]() (-24.33%) |
Filing History |
2025-02-14 12:03 pm Sale |
2024-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 1,234,834 3.730% |
-621,152![]() (-33.47%) |
Filing History |
2025-02-14 12:01 pm Purchase |
2024-12-31 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 2,220,000 3.460% |
2,220,000![]() (New Position) |
Filing History |
2025-02-14 11:56 am Sale |
2024-12-31 | 13G | Aura Biosciences, Inc. AURA |
Eventide Asset Management, LLC | 4,080,605 8.170% |
-1,722,077![]() (-29.68%) |
Filing History |
2025-02-05 5:59 pm Purchase |
2025-01-31 | 13G | Beta Bionics, Inc. BBNX |
Eventide Asset Management, LLC | 4,857,041 11.320% |
4,857,041![]() (New Position) |
Filing History |
2024-11-14 12:27 pm Sale |
2024-09-30 | 13G | Xometry, Inc. XMTR |
Eventide Asset Management, LLC | 4,418,664 9.480% |
-1,309,106![]() (-22.86%) |
Filing History |
2024-11-14 12:25 pm Purchase |
2024-09-30 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 3,445,363 7.220% |
751,782![]() (+27.91%) |
Filing History |
2024-11-14 12:24 pm Sale |
2024-09-30 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Eventide Asset Management, LLC | 0 0.000% |
-4,529,997![]() (Position Closed) |
Filing History |
2024-11-14 12:23 pm Sale |
2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 1,855,986 5.610% |
-336,225![]() (-15.34%) |
Filing History |
2024-11-14 12:21 pm Sale |
2024-09-30 | 13G | Korro Bio, Inc. KRRO |
Eventide Asset Management, LLC | 391,166 4.210% |
-155,159![]() (-28.40%) |
Filing History |
2024-11-14 12:19 pm Purchase |
2024-09-30 | 13G | Inozyme Pharma, Inc. INZY |
Eventide Asset Management, LLC | 4,134,436 6.440% |
954,599![]() (+30.02%) |
Filing History |
2024-11-14 12:18 pm Sale |
2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX |
Eventide Asset Management, LLC | 3,332,005 5.030% |
-298,008![]() (-8.21%) |
Filing History |
2024-11-14 12:17 pm Purchase |
2024-09-30 | 13G | Nektar Therapeutics NKTR |
Eventide Asset Management, LLC | 9,400,000 5.110% |
9,400,000![]() (New Position) |
Filing History |
2024-11-06 2:47 pm Sale |
2024-10-31 | 13G | Zentalis Pharmaceuticals, Inc. ZNTL |
Eventide Asset Management, LLC | 7,090,108 9.970% |
-4,469,867![]() (-38.67%) |
Filing History |
2024-08-09 09:43 am Sale |
2024-07-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
Eventide Asset Management, LLC | 2,192,211 6.650% |
-810,620![]() (-27.00%) |
Filing History |
2024-02-14 12:49 pm Purchase |
2023-12-31 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
Eventide Asset Management, LLC | 2,693,581 5.780% |
636,581![]() (+30.95%) |
Filing History |
2024-02-14 12:43 pm Sale |
2023-12-31 | 13G | Annexon, Inc. ANNX |
Eventide Asset Management, LLC | 0 0.000% |
-3,626,508![]() (Position Closed) |
Filing History |